» Articles » PMID: 26359667

Bioinformatics-Based Identification of MicroRNA-Regulated and Rheumatoid Arthritis-Associated Genes

Overview
Journal PLoS One
Date 2015 Sep 12
PMID 26359667
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) act as epigenetic markers and regulate the expression of their target genes, including those characterized as regulators in autoimmune diseases. Rheumatoid arthritis (RA) is one of the most common autoimmune diseases. The potential roles of miRNA-regulated genes in RA pathogenesis have greatly aroused the interest of clinicians and researchers in recent years. In the current study, RA-related miRNAs records were obtained from PubMed through conditional literature retrieval. After analyzing the selected records, miRNA targeted genes were predicted. We identified 14 RA-associated miRNAs, and their sub-analysis in 5 microarray or RNA sequencing (RNA-seq) datasets was performed. The microarray and RNA-seq data of RA were also downloaded from NCBI Gene Expression Omnibus (GEO) and Sequence Read Archive (SRA), analyzed, and annotated. Using a bioinformatics approach, we identified a series of differentially expressed genes (DEGs) by comparing studies on RA and the controls. The RA-related gene expression profile was thus obtained and the expression of miRNA-regulated genes was analyzed. After functional annotation analysis, we found GO molecular function (MF) terms significantly enriched in calcium ion binding (GO: 0005509). Moreover, some novel dysregulated target genes were identified in RA through integrated analysis of miRNA/mRNA expression. The result revealed that the expression of a number of genes, including ROR2, ABI3BP, SMOC2, etc., was not only affected by dysregulated miRNAs, but also altered in RA. Our findings indicate that there is a close association between negatively correlated mRNA/miRNA pairs and RA. These findings may be applied to identify genetic markers for RA diagnosis and treatment in the future.

Citing Articles

A polygenic score method boosted by non-additive models.

Ohta R, Tanigawa Y, Suzuki Y, Kellis M, Morishita S Nat Commun. 2024; 15(1):4433.

PMID: 38811555 PMC: 11522481. DOI: 10.1038/s41467-024-48654-x.


M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics.

Huang Y, Xue Q, Chang J, Wang Y, Cheng C, Xu S Arthritis Res Ther. 2023; 25(1):189.

PMID: 37784134 PMC: 10544321. DOI: 10.1186/s13075-023-03149-w.


microRNA-23 inhibits inflammation to alleviate rheumatoid arthritis via regulating CXCL12.

Gao B, Sun G, Wang Y, Geng Y, Zhou L, Chen X Exp Ther Med. 2021; 21(5):459.

PMID: 33777193 PMC: 7967800. DOI: 10.3892/etm.2021.9890.


Retinoic Acid-Platinum (II) Complex [RT-Pt(II)] Protects Against Rheumatoid Arthritis in Mice via MEK/Nuclear Factor kappa B (NF-κB) Pathway Downregulation.

Cui Z, Lin Y, Liu Y, Cao L, Cui L Med Sci Monit. 2020; 26:e924787.

PMID: 32741960 PMC: 7418485. DOI: 10.12659/MSM.924787.


Nociceptive related microRNAs and their role in rheumatoid arthritis.

Reyes-Long S, Cortes-Altamirano J, Clavijio-Cornejo D, Gutierrez M, Bertolazzi C, Bandala C Mol Biol Rep. 2020; 47(9):7265-7272.

PMID: 32740794 DOI: 10.1007/s11033-020-05700-3.


References
1.
Khurana R, Wolf R, Berney S, Caldito G, Hayat S, Berney S . Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. J Rheumatol. 2008; 35(9):1704-8. View

2.
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J, Fahmi H . Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010; 7(1):33-42. DOI: 10.1038/nrrheum.2010.196. View

3.
Feldmann M . Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002; 2(5):364-71. DOI: 10.1038/nri802. View

4.
Katoh Y, Katoh M . Comparative genomics on Dkk1 orthologs. Int J Oncol. 2005; 27(1):275-9. View

5.
Li J, Wan Y, Guo Q, Zou L, Zhang J, Fang Y . Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther. 2010; 12(3):R81. PMC: 2911863. DOI: 10.1186/ar3006. View